AstraZeneca gets marketing authorization for Roxadustat in China to treat anaemia caused by CKD Medical Dialogues Bureau22 Aug 2019 9:20 AM ISTThis marketing authorization follows the approval of Roxadustat in China in December 2018 for anaemia in CKD patients who are on dialysis. AstraZeneca...
GSK: US pharma president Jack Bailey to step down in December Medical Dialogues Bureau22 Aug 2019 9:15 AM ISTCommenting on his time at GSK, Jack Bailey said, "After more than a decade at GSK and nearly three decades in the life sciences industry, I look...
Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh Medical Dialogues Bureau21 Aug 2019 10:00 AM ISTThe audit of Dr Reddy's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug...
Alembic Pharma clears USFDA inspection at Bioequivalence facility in Vadodara Medical Dialogues Bureau21 Aug 2019 9:45 AM ISTNew Delhi: Drug firm, Alembic Pharmaceutical's bioequivalence facilities located at Vadodara have been successfully inspected by the US Food &...
Dr Reddy's launches generic version of Sabril powder in US to treat epilepsy Medical Dialogues Bureau21 Aug 2019 9:30 AM ISTDr Reddy's anti-epileptic Vigabatrin is a generic version of Lundbeck's Sabril powder for oral solution.New Delhi: Drug firm Dr Reddy's Laboratories...
Teva Pharma unveils generic version of EpiPen for children at USD 300 for 2 packs Medical Dialogues Bureau21 Aug 2019 9:15 AM ISTTeva Pharma, the world’s largest generic drugmaker, is already selling the product for adults, after getting U.S. approval for its copy of EpiPen last...
Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion Medical Dialogues Bureau21 Aug 2019 9:00 AM ISTBayer said in a statement that the sale, aimed at sharpening the company's focus on life sciences, was expected to be concluded in mid-2020 pending...
Dr Reddy's unveils VERSAVO, biosimilar to Roche Avastin to treat types of cancers in India Medical Dialogues Bureau20 Aug 2019 10:00 AM ISTAccording to Ipsos India Tandem Oncology Monitor 2018, Avastin and its biosimilars had India sales of around Rs 223 crore (moving annual total) MAT...
Glenmark wins regulatory nod to market diabetes drug under brand names Remo-M, Remozen-M in India Medical Dialogues Bureau20 Aug 2019 9:45 AM ISTGlenmark Pharma will commercialise the combination of Remogliflozin etabonate and Metformin hydrochloride film-coated tablets in India under the brand...
Boston Scientific gets USFDA approval for ImageReady MRI labelling for Vercise Gevia DBS System Farhat Nasim20 Aug 2019 9:30 AM ISTMARLBOROUGH: Boston Scientific Corporation recently announced the U.S. Food and Drug Administration (USFDA) approval of its ImageReady MRI labelling...
Sarepta Therapeutic fails to win USFDA approval for second Duchenne treatment Golodirsen Medical Dialogues Bureau20 Aug 2019 9:15 AM ISTAnalysts had expected annual sales of nearly $400 million in five years for golodirsen, the second treatment from Sarepta for DMD, a rare...
Roche names Eli Lilly executive Levi Garraway as chief medical officer Medical Dialogues Bureau20 Aug 2019 9:00 AM ISTLevi Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel target...
